コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n plasma; and (d) a novel empirical model of hypoxic pulmonary vasoconstriction.
2 icates pulmonary hypertension and attenuated hypoxic pulmonary vasoconstriction.
3 elium-dependent vasodilatation, and enhanced hypoxic pulmonary vasoconstriction.
4 er increases in [Ca(2+)](i) that cause acute hypoxic pulmonary vasoconstriction.
5 exacerbated by endotoxin-mediated failure of hypoxic pulmonary vasoconstriction.
6 l, to the pulmonary selectivity required for hypoxic pulmonary vasoconstriction.
7 ity in acute hypoxia, consistent with uneven hypoxic pulmonary vasoconstriction.
8 lar oxygen signal responsible for triggering hypoxic pulmonary vasoconstriction.
9 ponsible for the modulatory effects of pH on hypoxic pulmonary vasoconstriction.
10 arterial resistance is most consistent with hypoxic pulmonary vasoconstriction.
11 ient mice, sildenafil markedly blunted acute hypoxic pulmonary vasoconstriction.
12 tes for the K(+) channel isoforms initiating hypoxic pulmonary vasoconstriction.
13 receptor activity of epinephrine attenuated hypoxic pulmonary vasoconstriction.
14 of a combination of reduced blood volume and hypoxic pulmonary vasoconstriction.
15 emia may be explained in part by the loss of hypoxic pulmonary vasoconstriction.
16 fusion matching governed by the mechanism of hypoxic pulmonary vasoconstriction.
17 ays an influential role in the modulation of hypoxic pulmonary vasoconstriction.
18 decreases in Pao2/Fio2 ratio, and a loss of hypoxic pulmonary vasoconstriction (48 hrs, -90.5% vs. b
20 nce hypoxia, the functional response, termed hypoxic pulmonary vasoconstriction, activates a multitud
21 not understood how the integrated action of hypoxic pulmonary vasoconstriction affects oxygen transp
27 mitochondrial metabolism by hypoxia to acute hypoxic pulmonary vasoconstriction and progression of pu
28 therapeutic option to counteract the loss of hypoxic pulmonary vasoconstriction and redistribute bloo
30 by HbFe(II)NO-bearing RBCs may contribute to hypoxic pulmonary vasoconstriction and the rebound effec
33 ondria function as the O2 sensors underlying hypoxic pulmonary vasoconstriction by releasing reactive
34 In summary, at 3800 m both hypovolaemia and hypoxic pulmonary vasoconstriction contribute to the dec
35 lmonary microvessels and is the mechanism of hypoxic pulmonary vasoconstriction failure associated wi
36 provides evidence for a severe impairment of hypoxic pulmonary vasoconstriction following combined bu
38 iction matches perfusion to ventilation; (2) hypoxic pulmonary vasoconstriction homogenizes regional
40 sponsible for sensing hypoxia and initiating hypoxic pulmonary vasoconstriction (HPV) are unclear.
41 hemoglobin (Hb) and red blood cells augment hypoxic pulmonary vasoconstriction (HPV) by scavenging n
43 lar analogue methazolamide prevent or reduce hypoxic pulmonary vasoconstriction (HPV) in dogs and hum
44 CA) inhibitors such as acetazolamide inhibit hypoxic pulmonary vasoconstriction (HPV) in humans and o
54 binoid anandamide (AEA) is a key mediator of hypoxic pulmonary vasoconstriction (HPV) via fatty acid
55 tial to avoid life-threatening hypoxemia via hypoxic pulmonary vasoconstriction (HPV) which matches p
57 a potential site of O(2) sensing underlying hypoxic pulmonary vasoconstriction (HPV), but 2 disparat
69 ry vessels, which may explain the failure of hypoxic pulmonary vasoconstriction in acute respiratory
70 3) dipyridamole blunts the severity of acute hypoxic pulmonary vasoconstriction in children with exag
71 oxical findings may be explained by impaired hypoxic pulmonary vasoconstriction in infected lung regi
73 nd combined contribution of hypovolaemia and hypoxic pulmonary vasoconstriction in limiting left vent
74 of the proximal region of the ETC attenuates hypoxic pulmonary vasoconstriction in rat lungs and bloc
77 tude include hyperventilation, polycythemia, hypoxic pulmonary vasoconstriction-increased intracellul
78 onal alveolar-capillary oxygen flux; and (3) hypoxic pulmonary vasoconstriction increases whole-lobe
83 thesis of the etiology of HAPE suggests that hypoxic pulmonary vasoconstriction is extensive but not
84 striction and attempted to determine whether hypoxic pulmonary vasoconstriction is influenced by pyri
88 on of a uniform ventilation distribution (1) hypoxic pulmonary vasoconstriction matches perfusion to
89 addition to airway obstruction, the loss of hypoxic pulmonary vasoconstriction may help to explain w
90 hanism also may be an important component of hypoxic pulmonary vasoconstriction, memory, and circadia
92 d and combined influence of hypovolaemia and hypoxic pulmonary vasoconstriction on the decrease in le
94 n polyoxyethylene conjugate had no effect on hypoxic pulmonary vasoconstriction or pulmonary shunt.
96 We found that dasatinib treatment attenuated hypoxic pulmonary vasoconstriction responses and increas
97 shunt or may worsen oxygenation by reversing hypoxic pulmonary vasoconstriction, therapy increasing v
98 arterial smooth muscle cells responsible for hypoxic pulmonary vasoconstriction to limit perfusion of
103 asma volume was normalised to SL values, and hypoxic pulmonary vasoconstriction was reversed by admin
104 redictions of a computer lung model in which hypoxic pulmonary vasoconstriction was suppressed by end
105 greater resting hypoxaemia, they had similar hypoxic pulmonary vasoconstriction when compared to lowl
106 Inhaled nitric oxide was able to abolish hypoxic pulmonary vasoconstriction when insufflated into
107 triction; (ii) sympathoexcitation; and (iii) hypoxic pulmonary vasoconstriction with respect to alter
108 lation of ENO provided immediate relief from hypoxic pulmonary vasoconstriction without affecting sys